{"product_id":"ecgf1-antibody-sc-f1467","title":"Thymidine Phosphorylase\/ECGF1 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eECGF1 is a target of interest in many antibody-based workflows. Thymidine phosphorylase (TP), also known as platelet-derived endothelial cell growth factor, is an enzyme that catalyzes the reversible conversion of thymidine to thymine and 2-deoxy-D-ribose-1-phosphate (2DDR1P). The 2DDR1P is further dephosphorylated to form a more stable molecule, 2-deoxy-D-ribose (2DDR). TP is present in various normal tissues and is involved in wound healing and chronic inflammatory diseases. Depending on the literature source, ECGF1 may also be discussed as Thymidine Phosphorylase\/ECGF1 and Thymidine Phosphorylase.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytosol, which can matter when signal is compared across treatments or changing cell states. Following ECGF1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eECGF1 is commonly interpreted in the context of cancer research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytosol, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003esignal enrichment within cytosol relative to the broader cellular background\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003edifferences between total target abundance and site-specific regulation when modified forms are compared\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for ECGF1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in ECGF1 reflect biology rather than handling. When interpreting ECGF1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep ECGF1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577753575769,"sku":"F1467-20UL","price":149.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577753608537,"sku":"F1467-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577753641305,"sku":"F1467-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F1467-wb.gif?v=1773599782","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/ecgf1-antibody-sc-f1467","provider":"Absource Diagnostics","version":"1.0","type":"link"}